Migdal Insurance & Financial Holdings Ltd. Htg Molecular Diagnostics, Inc Transaction History

Migdal Insurance & Financial Holdings Ltd.

  • $6.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022
SELL
$1.39 - $5.51 $1,829 - $7,251
-1,316 Closed
0 $0
Q4 2021

Feb 02, 2022
SELL
$3.23 - $5.97 $2,561 - $4,734
-793 Reduced 37.6%
1,316 $7,000
Q3 2021

Nov 16, 2021
BUY
$5.01 - $6.8 $10,566 - $14,341
2,109 New
2,109 $12,000

Others Institutions Holding HTGM

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About HTG MOLECULAR DIAGNOSTICS, INC

HTGM Quotes by TradingView
  • Ticker HTGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 11,048,100
  • Market Cap $3.76M
  • Description
  • HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-o...
More about HTGM
Track This Portfolio

Track Migdal Insurance & Financial Holdings Ltd. Portfolio

Follow Migdal Insurance & Financial Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email